Clinical Trials

Showing 281 - 300 of 519 trials
Title Investigatorsort icon Disease(s)
A Phase I/II Study of Sunitinib in Young Patients with Advanced Gastrointestinal Stromal Tumors
Newly Diagnosed & Relapsed/Refractory
[Protocol 12-226]
Magnan, Heather
  • Sarcomas
    • Soft Tissue Sarcoma
  • Upper Gastrointestinal
A Pilot Trial of Irinotecan, Temozolomide, and Bevacizumab plus High-Dose Chemotherapy for Newly Diagnosed Patients with Desmoplastic Small Round Cell Tumor
[Protocol 10-091]
Magnan, Heather
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of Irinotecan and Temozolomide in Combination with Existing High-Dose Chemotherapy for Patients Newly Diagnosed with Ewing Sarcoma
[Protocol 13-068]
Magnan, Heather
  • Sarcomas
    • Ewing's Sarcoma
    • Soft Tissue Sarcoma
A Phase II Study of Dalantercept for Treating Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 13-109]
Makker, Vicky
  • Ovarian Cancer
A Phase I Study of Selinexor (KPT-330) with Paclitaxel and Carboplatin for Treating Advanced Ovarian and Endometrial Cancers
[Protocol 14-110]
Makker, Vicky
  • Ovarian Cancer
  • Uterine (Endometrial) Cancer
  • Uterine Sarcoma
    • Carcinosarcoma
A Phase II Trial of a WT-1 Vaccine in Patients with Acute Myeloid Leukemia
[Protocol 10-143]
Maslak, Peter
  • Leukemia
    • Acute Myelogenous Leukemia
Assessment of Heart Tissue in Survivors of Hodgkin Lymphoma
[Protocol 14-017]
Matasar, Matthew
  • Lymphoma
    • Hodgkin's Disease
  • Survivorship
A Phase I Study of ABL001 in Patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
[Protocol 14-168]
Mauro, Michael
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Chronic Myelocytic Leukemia
LIVESTRONG Young Adult Cancer Survivor Network Study
[Protocol 13-237]
McCabe, Mary
  • Survivorship
A Phase I Study of Oral AG-120 in Patients with Advanced Solid Tumors, Including Glioma, with an IDH1 Mutation
Relapsed/Refractory
[Protocol 14-068]
Mellinghoff, Ingo
  • Brain Tumors, Primary
    • Gliomas
  • Solid Tumors
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020]
Meyers, Paul
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients
[Protocol 03-123]
Meyers, Paul
  • Hematology
    • Hematologic Malignancies
  • Sarcomas
A Phase I Study of LDK378 in Children with Cancers Containing an ALK Mutation
Relapsed/Refractory
[Protocol 13-235]
Modak, Shakeel
  • Lymphoma
    • Non-Hodgkin's Lymphoma
  • Neuroblastoma
  • Sarcomas
    • Rhabdomyosarcoma
  • Solid Tumors
A Pilot Study of PET Imaging of Solid Tumors Using Radioactive Iodine-Labeled Hu3F8
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-147]
Modak, Shakeel
  • Melanoma
  • Neuroblastoma
  • Sarcomas
A Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
[Protocol 09-011]
Modak, Shakeel
  • Neuroblastoma
A Phase I Study of Intraperitoneal Radioimmunotherapy with 131I-8H9 for Patients with Desmoplastic Small Round Cell Tumors and Other Solid Peritoneal Tumors
[Protocol 09-090]
Modak, Shakeel
A Phase I Study of LJM716, BYL719, and Trastuzumab in Women with Metastatic HER2-Positive Breast Cancer
[Protocol 14-057]
Modi, Shanu
  • Breast Cancer
A Phase I Study of SGN-LIV1A in Women with Metastatic Breast Cancer
[Protocol 14-013]
Modi, Shanu
  • Breast Cancer
A Phase I Study of DLYE5953A in Patients with Advanced or Persistent Solid Tumors
[Protocol 14-089]
Modi, Shanu
  • Breast Cancer
  • Head & Neck Cancer
  • Hepatobiliary
    • Pancreatic Cancer
  • Lung Cancer, Non-Small Cell
  • Ovarian Cancer
  • Upper Gastrointestinal
    • Gastric Cancer
    • Pancreatic Cancer
A Phase I Study of Ganetespib with Paclitaxel and Trastuzumab in Women with Metastatic Breast Cancer
[Protocol 13-168]
Modi, Shanu
  • Breast Cancer